Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Phibro Animal Health (PAHC) Retained Earnings (2016 - 2025)

Phibro Animal Health (PAHC) has 13 years of Retained Earnings data on record, last reported at $317.0 million in Q4 2025.

  • For Q4 2025, Retained Earnings rose 336.25% year-over-year to $317.0 million; the TTM value through Dec 2025 reached $317.0 million, up 336.25%, while the annual FY2025 figure was -$124.0 million, 0.4% changed from the prior year.
  • Retained Earnings reached $317.0 million in Q4 2025 per PAHC's latest filing, up from -$124.0 million in the prior quarter.
  • Across five years, Retained Earnings topped out at $317.0 million in Q4 2025 and bottomed at -$134.2 million in Q4 2024.
  • Average Retained Earnings over 5 years is $44.7 million, with a median of -$114.6 million recorded in 2021.
  • Peak YoY movement for Retained Earnings: tumbled 154.88% in 2024, then surged 336.25% in 2025.
  • A 5-year view of Retained Earnings shows it stood at $232.3 million in 2021, then plummeted by 150.17% to -$116.5 million in 2022, then skyrocketed by 309.77% to $244.4 million in 2023, then tumbled by 154.88% to -$134.2 million in 2024, then surged by 336.25% to $317.0 million in 2025.
  • Per Business Quant database, its latest 3 readings for Retained Earnings were $317.0 million in Q4 2025, -$124.0 million in Q2 2025, and $260.3 million in Q1 2025.